Avantis International Equity ETF AVDE

Novo Nordisk Holds Its 2026 Outlook As FDA Review Of Its Blood Disorder Drug Runs Long $NVO $PPH $AVDE https://stocktwits.com/news/equity/markets/novo-holds-its-2026-outlook-as-fda-review-of-its-blood-disorder-drug-runs-long/cZDjsS6RBKY

NVO Stock On Track For Worst Week In Over 6 Months After Strategy Day — Direct US Listing Talks, Drug Approval Fail To Halt Slip $NVO $AVDE $PPH https://stocktwits.com/news/equity/markets/nvo-stock-on-track-for-worst-week-in-over-6-months-after-strategy-day-direct-us-listing-talks-drug-approval-fail-to-halt-slip/cZM4EFRRBBB

NVO Stock Jumps 4% As European Committee Backs Novo’s Haemophilia Pen $NVO $AVDE $PPH https://stocktwits.com/news/equity/markets/nvo-stock-jumps-4-as-european-committee-backs-novo-s-haemophilia-pen/cZtrx1oRBdm

AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss — Executive ‘Disappointed,’ Reiterates Breast Cancer Focus $AZN $PVAL $AVDE https://stocktwits.com/news/equity/markets/azn-stock-slips-after-hours-following-latest-late-stage-oncology-trial-miss-executive-disappointed-reiterates-breast-cancer-focus/cZtXD0GRBb0

NVO Stock Drops 6% Despite Raised Guidance As Investors Worry About Injectable GLP-1 Sales Future $NVO $AVDE $PPH https://stocktwits.com/news/equity/markets/nvo-stock-drops-6-despite-raised-guidance-as-investors-worry-about-injectable-glp-1-sales-future/cZo5Hg0RJ4i

NVO Stock Ends Three-Month Winning Streak As Novo Nordisk’s Key Heart Drug Flops, Competition Goes To Court $NVO $AVDE $PPH https://stocktwits.com/news/equity/markets/nvo-stock-ends-three-month-winning-streak-novo-nordisk-s-key-heart-drug-flops-competition-goes-to-court/cZ8xiBeRJ5P

🌍 As AI and chip stocks stumble, investors are looking beyond U.S. tech. $VOO is down about 0.7% over the past month as AI worries deepen. 📊 Global diversification ideas include $AVDE $FNDF, value ETFs $EFV, and dividend ETFs $IDV. 🔗 Could international ETFs outperform VOO if AI-driven volatility persists? Read more here 👇 https://www.zacks.com/stock/news/2963563/global-etfs-to-diversify-as-tech-weakness-weighs-on-markets?_gl=1%2Ay96eec%2A_up%2AMQ..%2A_ga%2AMTA0NDc2NDE4My4xNzg1NDg0OTI0%2A_ga_MXXMZ1PBF7%2AczE3ODU0ODQ5MjQkbzEkZzAkdDE3ODU0ODQ5MjQkajYwJGwwJGg2MDcwNzI1OTc.&cid=sm-stocktwits-0-2963563-oc-39060&ADID=SYND_STOCKTWITS_TWEET_0_2963563_OC_39060

NVO Stock Jumps 3% As EU Approves Oral Wegovy Pill — Retail Notes LLY Is ‘Clearly Behind’ Its Danish Counterpart $NVO $PVAL $AVDE $LLY https://stocktwits.com/news/equity/markets/nvo-stock-jumps-3-as-eu-approves-oral-wegovy-pill-retail-notes-lly-is-clearly-behind-its-danish-counterpart/cZZPaw9R7r9